Zinc Absorption From Biofortified Rice
This study is currently recruiting participants.
Verified June 2012 by Swiss Federal Institute of Technology
Sponsor:
Swiss Federal Institute of Technology
Collaborator:
University of Zurich
Information provided by (Responsible Party):
Prof. Michael B. Zimmermann, Swiss Federal Institute of Technology
ClinicalTrials.gov Identifier:
NCT01633450
First received: June 29, 2012
Last updated: NA
Last verified: June 2012
History: No changes posted
Tracking Information | |
---|---|
First Received Date ICMJE | June 29, 2012 |
Last Updated Date | June 29, 2012 |
Start Date ICMJE | June 2012 |
Estimated Primary Completion Date | August 2012 (final data collection date for primary outcome measure) |
Current Primary Outcome Measures ICMJE |
Fractional absorption of zinc [ Time Frame: 33 days ] [ Designated as safety issue: No ] Fractional absorption of zinc is estimated by using the double isotope tracer ratio technique by administering 67Zn as oral and 70Zn as intravenous stable isotopes.The urinary enrichment with both isotopes is measured in a spot urine sample by inductively coupled plasma mass spectrometry. |
Original Primary Outcome Measures ICMJE | Same as current |
Change History | No Changes Posted |
Current Secondary Outcome Measures ICMJE | |
Original Secondary Outcome Measures ICMJE | |
Current Other Outcome Measures ICMJE | |
Original Other Outcome Measures ICMJE | |
Descriptive Information | |
Brief Title ICMJE | Zinc Absorption From Biofortified Rice |
Official Title ICMJE | Bioavailability of Zinc From Rice Biofortified With 70Zn and Rice Extrinsically Labeled With 70Zn in Young Adults: a Randomized, Single-blind Study |
Brief Summary | One of the newest strategies to combat micronutrient deficiencies is the biofortification of staple foods, where higher levels of minerals are obtained through breeding of staple crops. The aim of this study is to evaluate zinc absorption from a rice biofortified with zinc when compared with a control rice fortified with zinc just before consumption. |
Detailed Description | |
Study Type ICMJE | Interventional |
Study Phase | |
Study Design ICMJE | Allocation: Randomized Intervention Model: Crossover Assignment Masking: Single Blind (Subject) |
Condition ICMJE | Healthy |
Intervention ICMJE |
|
Study Arm (s) |
|
Publications * | |
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|
Recruitment Information | |
Recruitment Status ICMJE | Recruiting |
Estimated Enrollment ICMJE | 16 |
Estimated Completion Date | August 2012 |
Estimated Primary Completion Date | August 2012 (final data collection date for primary outcome measure) |
Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
Gender | Both |
Ages | 18 Years to 45 Years |
Accepts Healthy Volunteers | Yes |
Contacts ICMJE | |
Location Countries ICMJE | Switzerland |
Administrative Information | |
NCT Number ICMJE | NCT01633450 |
Other Study ID Numbers ICMJE | HNL/CTC12-Reis |
Has Data Monitoring Committee | |
Responsible Party | Prof. Michael B. Zimmermann, Swiss Federal Institute of Technology |
Study Sponsor ICMJE | Swiss Federal Institute of Technology |
Collaborators ICMJE | University of Zurich |
Investigators ICMJE | |
Information Provided By | Swiss Federal Institute of Technology |
Verification Date | June 2012 |
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |